China Greenlight Registry Study (Post-market)
NCT03736512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-11-15
Summary
The duration of the study is expected to take approximately 3 years, which includes a recruitment period of approximately 12-months and 2 years (24-months) to complete procedure and follow-up visits.
Conditions
- Benign Prostatic Hyperplasia (BPH)
Interventions
- DEVICE
-
GreenLight XPS™ 532 nm Laser System with MoXy™ laser fiber
observational registry
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Jian Huang, Doctor · Sun Yat-sen Memorial Hosptital, Sun Yat-sen University
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-27
- Primary Completion
- 2021-03-30
- Completion
- 2021-11-29
Countries
- China
Study Locations
More Related Trials
-
Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours
NCT02401581 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer
NCT02761889 ·Status: COMPLETED ·Phase: NA
-
Medical and Economic Evaluation for Intermediate-risk Prostate Cancer
NCT02271659 ·Status: UNKNOWN ·Phase: NA
-
SpaceIT Hydrogel System for Perirectal Spacing
NCT06451614 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects
NCT00918229 ·Status: COMPLETED ·Phase: NA
-
MRI Prostate for Chinese Men Being Screened for Prostate Cancer
NCT03891732 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy
NCT00462124 ·Status: COMPLETED ·Phase: NA
-
Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)
NCT01494337 ·Status: COMPLETED ·Phase: PHASE4
-
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer
NCT01792024 ·Status: COMPLETED ·Phase: NA
-
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT05183074 ·Status: RECRUITING ·Phase: NA
-
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer
NCT06262633 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721 ·Status: RECRUITING ·Phase: PHASE2
-
Focal Therapy for Localized Prostate Cancer
NCT03970863 ·Status: WITHDRAWN
-
Evaluation of the Application Effect of a Surgical Navigation System in HoLEP Surgery
NCT07251621 ·Status: COMPLETED ·Phase: NA
-
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
NCT06526299 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer
NCT05073653 ·Status: UNKNOWN ·Phase: NA
-
Phase I Study MR-guided SBRT to PCa
NCT03935308 ·Status: WITHDRAWN ·Phase: NA
-
Rectal Spacers Use in Prostate Cancer Radiation Therapy
NCT06594887 ·Status: RECRUITING ·Phase: NA
-
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
MRI Guided SBRT for Localized Prostate Cancer
NCT03778112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer
NCT02974231 ·Status: COMPLETED
-
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
NCT02163317 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer
NCT00756392 ·Status: COMPLETED ·Phase: NA
-
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314535 ·Status: COMPLETED
-
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
NCT01982786 ·Status: COMPLETED ·Phase: NA